Alnylam Pharmaceuticals (ALNY.MX) Q3 2016 Earnings

4AugConfirmed
Q4 2015
Q1 2016
Q2 2016
Q3 2016
-23.6
-20.82
-18.04
-15.25

Details

Expected EPS
-23.6015625
Actual EPS
-19.825312500000003
Surprise EPS
3.78
Surprise Percent
+16%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -19.825312500000003 per share for Q3 2016.

0 Comments

Share your thoughts